Department of Nephrology and Endocrinology, University of Tokyo, Tokyo, Japan.
J Clin Invest. 2009 Oct;119(10):2868-78. doi: 10.1172/JCI39421. Epub 2009 Oct 1.
Sepsis is characterized by a severe inflammatory response to infection, and its complications, including acute kidney injury, can be fatal. Animal models that correctly mimic human disease are extremely valuable because they hasten the development of clinically useful therapeutics. Too often, however, animal models do not properly mimic human disease. In this Review, we outline a bedside-to-bench-to-bedside approach that has resulted in improved animal models for the study of sepsis - a complex disease for which preventive and therapeutic strategies are unfortunately lacking. We also highlight a few of the promising avenues for therapeutic advances and biomarkers for sepsis and sepsis-induced acute kidney injury. Finally, we review how the study of drug targets and biomarkers are affected by and in turn have influenced these evolving animal models.
脓毒症的特征是严重的感染炎症反应,其并发症,包括急性肾损伤,可能是致命的。能够正确模拟人类疾病的动物模型是非常有价值的,因为它们加速了具有临床应用价值的治疗方法的发展。然而,动物模型往往不能正确模拟人类疾病。在这篇综述中,我们概述了一种从床边到实验室再到床边的方法,该方法已经改进了用于脓毒症研究的动物模型,脓毒症是一种复杂的疾病,目前缺乏预防和治疗策略。我们还强调了一些有希望的脓毒症和脓毒症引起的急性肾损伤治疗进展和生物标志物的途径。最后,我们回顾了药物靶点和生物标志物的研究如何受到这些不断发展的动物模型的影响,以及反过来又如何影响这些动物模型。